Page 11 - PowerPoint Presentation
P. 11
Timeline of capital and revenue targets
Heme B Heme A
$25M revenue target $125M revenue target
2023 2024 2025 2026 2027
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Heme B
$3M program
Heme A
$5M facility
$5M reserve
Colorectal
$15.0M program
Vaccine Platform $20.0M program
Pre-Series A: $3.0M Series A: Tranche 1 Series A: Tranche 2
